Seer, Inc. (NASDAQ:SEER – Get Rating) CEO Omid Farokhzad sold 4,800 shares of Seer stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $5.12, for a total transaction of $24,576.00. Following the sale, the chief executive officer now owns 399,123 shares of the company's stock, valued at approximately $2,043,509.76. The sale was disclosed in a document filed with the SEC, which is available through this link.

Seer Trading Down 2.5 %

NASDAQ SEER opened at $5.11 on Friday. The company has a 50 day moving average price of $5.97 and a 200 day moving average price of $7.89. Seer, Inc. has a 52 week low of $3.92 and a 52 week high of $18.22.

Seer (NASDAQ:SEER – Get Rating) last posted its quarterly earnings data on Tuesday, November 8th. The company reported ($0.38) EPS for the quarter, hitting the consensus estimate of ($0.38). The firm had revenue of $3.96 million during the quarter, compared to analyst estimates of $3.71 million. Seer had a negative net margin of 646.27% and a negative return on equity of 18.80%. As a group, equities analysts forecast that Seer, Inc. will post -1.56 EPS for the current year.

Analyst Upgrades and Downgrades

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Envestnet Asset Management Inc. purchased a new stake in Seer during the 1st quarter worth approximately $261,000. Swiss National Bank grew its position in Seer by 7.8% during the 1st quarter. Swiss National Bank now owns 74,200 shares of the company's stock worth $1,131,000 after purchasing an additional 5,400 shares during the last quarter. Bank of New York Mellon Corp grew its position in Seer by 1.7% during the 1st quarter. Bank of New York Mellon Corp now owns 167,293 shares of the company's stock worth $2,549,000 after purchasing an additional 2,734 shares during the last quarter. MetLife Investment Management LLC grew its position in Seer by 57.0% during the 1st quarter. MetLife Investment Management LLC now owns 23,644 shares of the company's stock worth $360,000 after purchasing an additional 8,584 shares during the last quarter. Finally, First Trust Advisors LP purchased a new stake in Seer during the 1st quarter worth approximately $269,000. Institutional investors own 76.16% of the company's stock.

About Seer

(Get Rating)

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials.

See Also

• Get a free copy of the StockNews.com research report on Seer (SEER)
• MarketBeat Week in Review – 1/16 – 1/20
• Does Old Dominion Show That Trucking Is Hitting The Brakes?
• Nordstrom Puts Fear Of Markdowns Into Retail Sector
• Exxon Mobil Stock: Within Striking Distance Of Buy Point
• High-Dividend-Yielding BHP Sees China Driving '23 Growth

Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.